Stay updated on GLPG1690 in IPF: ISABELA2 Clinical Trial
Sign up to get notified when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.

Latest updates to the GLPG1690 in IPF: ISABELA2 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA 403 Forbidden error is displayed for the study record, replacing the usual content and hiding the study documents and sections from view.SummaryDifference18%

- Check32 days agoChange DetectedThe platform revision was updated from v3.6.6 to v3.7.0, indicating a deployment update.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page's revision metadata updated from v3.6.5 to v3.6.6. This reflects a newer release version on the site without changes to visible content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe study record now includes '2018 ( U.S. NIH Grant/Contract )' in the identifiers section, adding NIH funding information to the page.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, signaling a minor update to the page rendering and underlying systems.SummaryDifference0.0%

Stay in the know with updates to GLPG1690 in IPF: ISABELA2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG1690 in IPF: ISABELA2 Clinical Trial page.